Altretamine

Antineoplastic agent CAS# 645-05-6

Altretamine

Catalog No. BCC1216----Order now to get a substantial discount!

Product Name & Size Price Stock
Altretamine:5mg $49.00 In stock
Altretamine:10mg $83.00 In stock
Altretamine:25mg $196.00 In stock
Altretamine:50mg $343.00 In stock
Related Products

Quality Control of Altretamine

Number of papers citing our products

Chemical structure

Altretamine

3D structure

Chemical Properties of Altretamine

Cas No. 645-05-6 SDF Download SDF
PubChem ID 2123 Appearance Powder
Formula C9H18N6 M.Wt 210.28
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : 8.33 mg/mL (39.61 mM; Need ultrasonic)
H2O : < 0.1 mg/mL (insoluble)
Chemical Name 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
SMILES CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C
Standard InChIKey UUVWYPNAQBNQJQ-UHFFFAOYSA-N
Standard InChI InChI=1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Altretamine Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Altretamine Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Altretamine

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 4.7556 mL 23.7778 mL 47.5556 mL 95.1113 mL 118.8891 mL
5 mM 0.9511 mL 4.7556 mL 9.5111 mL 19.0223 mL 23.7778 mL
10 mM 0.4756 mL 2.3778 mL 4.7556 mL 9.5111 mL 11.8889 mL
50 mM 0.0951 mL 0.4756 mL 0.9511 mL 1.9022 mL 2.3778 mL
100 mM 0.0476 mL 0.2378 mL 0.4756 mL 0.9511 mL 1.1889 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Altretamine

Altretamine is an antitumor agent which also acts as a chemosterilant for male houseflies and other insects. Altretamine is also an antineoplastic.

Featured Products
New Products
 

References on Altretamine

Altretamine.[Pubmed:1905441]

DICP. 1991 Feb;25(2):146-52.

Altretamine is a National Cancer Institute-designated group C antineoplastic agent used in the treatment of advanced ovarian cancer. Altretamine is a highly lipid-soluble drug available only for oral administration as a capsule. The drug is activated through metabolic oxidation to intermediate methylol derivatives and formaldehyde. It is unclear which metabolite is the major species responsible for cytotoxicity or the primary mechanism of cytotoxicity. As a single agent in the treatment of ovarian cancer, Altretamine demonstrates a response rate similar to other active agents in this disease (21-39 percent). The major utility of Altretamine is in combination with other agents such as cyclophosphamide, doxorubicin, fluorouracil, melphalan, and cisplatin. However, few randomized trials have evaluated the contribution of Altretamine in these multiagent combinations. Dose-limiting toxicities include gastrointestinal (nausea, vomiting, anorexia), hematologic, and neurotoxic (peripheral neurotoxicity). The therapeutic role of Altretamine is limited because of a toxicity profile similar to that of cisplatin, one of the more active agents in ovarian cancer. Its use should be reserved for patients who are not candidates for more standard platinum-based regimens.

Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.[Pubmed:7641606]

Drugs. 1995 Jun;49(6):932-53.

Altretamine (hexamethylmelamine) is a cytotoxic antineoplastic agent which appears to require metabolic activation. Metabolic intermediates may act as alkylating agents; however, Altretamine is not directly cross-resistant with classical alkylating agents. Objective response rates to orally administered Altretamine as salvage therapy in patients with advanced ovarian cancer were 0 to 33%, with disease stabilisation in a further 8 to 78% of patients. Response rates appear to be higher in patients who have responded to previous alkylating agent or cisplatin-based therapy. There is some evidence that addition of Altretamine to platinum-based combination regimens used for induction therapy of advanced ovarian cancer may improve long term survival, particularly in patients with limited residual disease. Although Altretamine displays some activity in small cell lung cancer, it is unlikely to have any clinical role in the management of non-ovarian cancer. Altretamine appears to be relatively well tolerated, with gastrointestinal, neurological and haematological toxicities being the main dose-limiting adverse effects. However, assessment of accurate incidence rates for these effects is complicated by the use of Altretamine with cisplatin. On the basis of the emerging body of clinical evidence, Altretamine appears to have a limited role in the treatment of persistent or recurrent advanced ovarian cancer, primarily in patients who are potentially platinum sensitive yet intolerant of platinum analogues. Additionally, Altretamine may be added to platinum-based regimens for induction therapy of advanced ovarian cancer. At the doses currently recommended, Altretamine offers a reasonably well tolerated regimen that can be administered orally and is suitable for use on an outpatient basis.

Description

Altretamine is an alkylating antineoplastic agent.

Keywords:

Altretamine,645-05-6,Natural Products,DNA Alkylating, buy Altretamine , Altretamine supplier , purchase Altretamine , Altretamine cost , Altretamine manufacturer , order Altretamine , high purity Altretamine

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: